Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Avantium Knowledge Centre B.V. currently has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. All 3 of these actions are concentrated within 1 distinct art unit. This indicates a very specific technical focus for the company's current biotechnology and pharmaceutical innovations. The presence of 3 pending office actions reflects a moderate level of activity within this specialized field.
The company's prosecution is handled by 3 distinct examiners, meaning each pending action is being reviewed by a different person. NGUYEN, HA S is the busiest examiner, holding 1 busiest examiner pending action. This shows that the 3 pending office actions are distributed equally among the 3 distinct examiners. This distribution provides the company with multiple perspectives from different examiners at the patent office.
The alignment of 3 pending office actions within 1 distinct art unit suggests that while the examiners are different, they likely follow the same departmental guidelines. However, the company must still navigate the individual preferences of NGUYEN, HA S and the other examiners. This combination of 1 distinct art unit and 3 distinct examiners requires a strategy that is technically consistent but personally tailored. Practitioners should analyze the history of NGUYEN, HA S within the Biotechnology & Pharmaceuticals field to optimize their response.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, HA S | 1 | 58.7% | -21.0% |
| YOON, TAE H | 1 | 66.5% | +24.7% |
| MURESAN, ANA Z | 1 | 75.0% | +31.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18714491 | PROCESS FOR THE PRODUCTION OF POLYESTER COPOLYMERS | NGUYEN, HA S | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294919 | PROCESS FOR THE PRODUCTION OF POLYESTER COPOLYMERS | YOON, TAE H | — |
| 18268422 | PROCESS FOR PREPARING OXALATE AND OXALIC ACID WITH HYDRIDE CATALYST | MURESAN, ANA Z | — |
| Art Unit | Apps |
|---|---|
| 1692 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18714491 | PROCESS FOR THE PRODUCTION OF POLYESTER COPOLYMERS | NGUYEN, HA S | — | §102§103§112 | Non-Final OA | — | Pending | May 29, 2024 |
| 18294919 | PROCESS FOR THE PRODUCTION OF POLYESTER COPOLYMERS | YOON, TAE H | — | §112 | Non-Final OA | — | Pending | Feb 02, 2024 |
| 18268422 | PROCESS FOR PREPARING OXALATE AND OXALIC ACID WITH HYDRIDE CATALYST | MURESAN, ANA Z | 1692 | §103 | Final Rejection | — | Pending | Jun 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial